Microtek Medical Holdings, Inc., formerly known as Isolyser Company, Inc., develops, manufactures and markets proprietary and other products and services for patient care, occupational safety and management of potentially infectious and hazardous waste, primarily for the domestic healthcare market. The Company has two primary operating units, Microtek Medical, Inc. (Microtek) and OREX Technologies International (OTI). Microtek manufactures and sells infection-control products, such as equipment drapes and patient drapes primarily for use in operating rooms and outpatient surgical centers. OTI seeks to develop and commercialize contamination-control materials and products coupled with engineered systems for the treatment and disposal of those materials.
Financial Summary Microtek Medical Holdings, Inc. offers high-performance contamination-control materials and products coupled with engineered systems for the treatment and disposal of those materials and products. For the fiscal year ended 12/02, revenues rose 7% to $86.7 million. Net income rose 76% to $8.4 million. Revenues reflect the acquisition of the drapeand CleanOp product lines by Microtek. Earnings also reflect reductions in product development costs.
Ownership
· Insider and 5%+ Owners: -0% · Institutional: 11% (11% of float) (36 institutions) · Net Inst. Buying: 142.0K shares (+3.09%) (prior quarter to latest quarter)
Statistics at a Glance -- NasdaqNM:MTMD
As of 23-Apr-2003
Price and Volume
52-Week Low on 7-Oct-2002 $0.88 Recent Price $2.45 52-Week High on 25-Apr-2002 $3.40 Beta 1.73 Daily Volume (3-month avg) 54.6K Daily Volume (10-day avg) 50.0K
as of 4-24-03; Last Trade 3:57pm · 2.80 Change +0.35 (+14.29%) Prev Cls 2.42 Open 2.48 Volume 249,350 Day's Range 2.46 - 2.84 Bid 2.67 Ask 2.83 P/E 12.10 Mkt Cap 117.8M Avg Vol 54,590 52-wk Range 0.88 - 3.55
Stock Performance
52-Week Change -25.5% 52-Week Change relative to S&P500 -11.4%
Microtek Medical Holdings Appoints KPMG as New Auditor 5:30 pm - PR Newswire
Thursday April 10, 2003
Microtek Medical Holdings Schedules Quarterly Earnings Release and Conference Call 9:01 am - PR Newswire
Thursday March 27, 2003
Annual Report with 10K for Microtek Medical Holdings 4:59 am - WILink
Monday February 24, 2003
Still More Upside Possible for Microtek 3:21 pm - RealCommentary from TheStreet.com
Wednesday February 19, 2003
Microtek Medical Holdings Reports Fourth Quarter and Full Year Results; Updates Revenue and Earnings Forecasts for FY 2003 8:48 am - PR Newswire
Q4 2002 MICROTEK MEDICAL HLDGS INC Earnings Release - Before Market Open 7:07 am - CCBN
Monday February 3, 2003
Microtek Medical Holdings Schedules Annual Earnings Release and Conference Call 8:32 am - PR Newswire
Tuesday December 24, 2002
Microtek Medical Is Set for a Happy New Year 6:59 am - RealCommentary from TheStreet.com
Monday November 11, 2002
Just a Matter of Time for Microtek 4:06 pm - RealCommentary from TheStreet.com
----ALSO note they have a share repurchase plan in place!----
During 2002, the Company utilized cash to finance the purchase of the drape product line of Gyrus ENT, to purchase property and equipment, to repay borrowings under its Credit Agreement, to make other scheduled debt repayments related to previous acquisitions of businesses, to make payments under equipment and capital leases and to repurchase shares of common stock under the Company’s stock repurchase program. During 2001, the Company utilized cash to fund working capital requirements, to finance the purchase of the drape and CleanOp product lines from Deka Medical and certain OREXTM processing equipment and related technology from MICROBasix LLC, to purchase other property and equipment, and to make scheduled debt repayments and payments under equipment and capital leases.
The $10.2 million provided by operating activities results principally from improved profitability and improved working capital management, particularly in the areas of accounts receivable and inventory management. Cash provided by operating activities was also impacted by increases in accounts payable and other accrued liabilities. Offsetting these increases in operating cash were increases in prepaid expenses and decreases in accrued compensation and other liabilities. The $2.5 million used in operating activities in 2001 results principally from the Company’s significant increases in inventories and accounts receivable resulting from increased sales. Also contributing to the use of cash in operating activities in 2001 were the decreases in accounts payable and the increases in prepaid expenses and other assets, which were partially offset by increases in accrued compensation and other liabilities. During 2002, cash used in investment activities consisted of acquisition costs of $4.1 million for the drape product line of Gyrus ENT and $1.5 million in capital property and equipment. Capital additions were primarily for building improvements, machinery and equipment, including computer equipment and software. During 2001, cash used in investing activities included acquisition costs of $11.6 million for the drape and CleanOp product lines from Deka Medical and $675,000 for certain OREX processing equipment and related technology from MICROBasix LLC. Also during 2001, the Company invested $1.1 million in capital property and equipment primarily associated with the Company’s expanded manufacturing operations in the Dominican Republic and investments to improve the Company’s internal management information systems. Cash used in financing activities in 2002 was $5.6 million, as compared to cash provided by financing activities in 2001 of $12.1 million. In 2002, the Company reduced its borrowings under its credit agreement by $5.3 million, repaid notes payable of approximately $664,000, and repurchased 369,000 shares of common stock for an aggregate amount of $678,000. Proceeds from the exercise of stock options and other issuances of common stock provided approximately $1.0 million in 2002.
============= I took a position at market this a.m. prior to posting the above